Insiders · Profile

Onyia Jude

Chief Scientific Officer at NEUROCRINE BIOSCIENCES. Filing since 29 Nov 2022. CIK 0001894425

Company

Date

Role

Action

Shares

Amount

Of holding

NBIX NEUROCRINE BIOSCIENCES INC

1 Jun 2026

Chief Scientific Officer

Sold on a plan

11,000

$1.76M

29.9%

NBIX NEUROCRINE BIOSCIENCES INC

27 May 2026

Chief Scientific Officer

Sold on a plan

11,000

$1.71M

29.9%

NBIX NEUROCRINE BIOSCIENCES INC

9 Jul 2025

Chief Scientific Officer

Sold on a plan

59,819

$7.80M

76.6%

NBIX NEUROCRINE BIOSCIENCES INC

2 Jul 2025

Chief Scientific Officer

Sold on a plan

20,362

$2.65M

52.7%

NBIX NEUROCRINE BIOSCIENCES INC

13 Feb 2025

Chief Scientific Officer

Sold on a plan

2,879

$336.24K

14.6%

NBIX NEUROCRINE BIOSCIENCES INC

31 Jan 2025

Chief Scientific Officer

Sold on a plan

126

$19.27K

0.8%

NBIX NEUROCRINE BIOSCIENCES INC

29 Nov 2024

Chief Scientific Officer

Sold on a plan

2,331

$294.37K

13.1%

NBIX NEUROCRINE BIOSCIENCES INC

13 Feb 2024

Chief Scientific Officer

Sold on a plan

1,432

$190.37K

9.8%

NBIX NEUROCRINE BIOSCIENCES INC

31 Jan 2024

Chief Scientific Officer

Sold on a plan

126

$17.88K

1.1%

NBIX NEUROCRINE BIOSCIENCES INC

29 Nov 2023

Chief Scientific Officer

Sold on a plan

2,331

$264.73K

16.6%

NBIX NEUROCRINE BIOSCIENCES INC

21 Aug 2023

Chief Scientific Officer

Sold on a plan

3,198

$343.37K

24.9%

NBIX NEUROCRINE BIOSCIENCES INC

7 Feb 2023

Chief Scientific Officer

Sold, plan not stated

4,508

$461.17K

40.9%

NBIX NEUROCRINE BIOSCIENCES INC

31 Jan 2023

Chief Scientific Officer

Sold, plan not stated

126

$13.67K

4.8%

NBIX NEUROCRINE BIOSCIENCES INC

29 Nov 2022

Chief Scientific Officer

Sold, plan not stated

2,331

$284.16K

49.6%

14 decisions on file.